Curcumin promotes a-beta fibrillation and reduces neurotoxicity in transgenic Drosophila

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Caesar, Ina ^a   Jonson, Maria ^a   Nilsson, K Peter R ^a   Thor, Stefan ^a   Hammarström, Per ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CURCUMIN; OLIGOMER; RECOMBINANT PROTEIN; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DROSOPHILA; DRUG EFFECT; GENOTYPE; IN VITRO STUDY; LIFESPAN; LOCOMOTION; LONGEVITY; NEUROTOXICITY; NONHUMAN; PROTEIN LOCALIZATION; TRANSGENIC ORGANISM; ANIMAL; METABOLISM; POLYMERIZATION; SURVIVAL RATE; TOXICITY AND INTOXICATION; TRANSGENIC ANIMAL; TREATMENT OUTCOME;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CURCUMIN; DROSOPHILA; GENOTYPE; NEUROTOXICITY SYNDROMES; POLYMERIZATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84856831983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031424     Document Type: Article

References (49)

1. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, et al. (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293: 711-714.
2. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, et al. (2004) Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A 101: 6623-6628.
3. Crowther DC, Kinghorn KJ, Miranda E, Page R, Curry JA, et al. (2005) Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132: 123-135.
4. Bilen J, Bonini NM, (2005) Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 39: 153-171.
5. Luheshi LM, Tartaglia GG, Brorsson AC, Pawar AP, Watson IE, et al. (2007) Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol 5: e290.
6. Nerelius C, Sandegren A, Sargsyan H, Raunak R, Leijonmarck H, et al. (2009) Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc Natl Acad Sci U S A 106: 9191-9196.
7. Luheshi LM, Hoyer W, de Barros TP, van Dijk Hard I, Brorsson AC, et al. (2010) Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. PLoS Biol 8: e1000334.
8. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, et al. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377.
9. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.
10. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, et al. (2008) Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 326: 196-208.
11. Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, et al. (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29: 9078-9089.
12. Qin XY, Cheng Y, Cui J, Zhang Y, Yu LC, (2009) Potential protection of curcumin against amyloid beta-induced toxicity on cultured rat prefrontal cortical neurons. Neurosci Lett 463: 158-161.
13. Wang YJ, Thomas P, Zhong JH, Bi FF, Kosaraju S, et al. (2009) Consumption of grape seed extract prevents amyloid-beta deposition and attenuates inflammation in brain of an Alzheimer's disease mouse. Neurotox Res 15: 3-14.
14. Ono K, Hasegawa K, Naiki H, Yamada M, (2004) Curcumin Has Potent Anti-Amyloidogenic Effects for Alzheimer's β-Amyloid Fibrils In Vitro. Journal of Neuroscience Research 75: 742-750.
15. Byeon SR, Lee JH, Sohn JH, Kim DC, Shin KJ, et al. (2007) Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Abeta fibril formation. Bioorg Med Chem Lett 17: 1466-1470.
16. Byun JH, Kim H, Kim Y, Mook-Jung I, Kim DJ, et al. (2008) Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation. Bioorg Med Chem Lett 18: 5591-5593.
17. Park SY, Kim HS, Cho EK, Kwon BY, Phark S, et al. (2008) Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol 46: 2881-2887.
18. Lin R, Chen X, Li W, Han Y, Liu P, et al. (2008) Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin. Neurosci Lett 440: 344-347.
19. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL, (2005) A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2: 131-136.
20. Hamaguchi T, Ono K, Murase A, Yamada M, (2009) Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 175: 2557-2565.
21. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ, (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102: 1095-1104.
22. Ryu EK, Choe YS, Lee KH, Choi Y, Kim BT, (2006) Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. J Med Chem 49: 6111-6119.
23. Ran C, Xu X, Raymond SB, Ferrara BJ, Neal K, et al. (2009) Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. J Am Chem Soc 131: 15257-15261.
24. Jurenka JS, (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 14: 141-153.
25. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, et al. (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76: 1590-1611.
26. Kodali R, Wetzel R, (2007) Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol 17: 48-57.
27. Wetzel R, Shivaprasad S, Williams AD, (2007) Plasticity of amyloid fibrils. Biochemistry 46: 1-10.
28. Brand AH, Perrimon N, (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 401-415.
29. Åslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, et al. (2009) Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chemical Biology 4: 673-684.
30. Berg I, Thor S, Hammarström P, (2009) Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster. Neurodegener Dis 6: 127-138.
31. Young MW, (2000) The tick-tock of the biological clock. Scientific American 282: 64-71.
32. Berg I, Nilsson KPR, Thor S, Hammarström P, (2010) Efficient Imaging of Amyloid Deposits in Drosophila Models of Human Amyloidoses. Nature Prot 5: 935-944.
33. Lord A, Philipson O, Klingstedt T, Westermark G, Hammarstrom P, et al. (2011) Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's Disease. The American journal of pathology 178: 2286-2298.
34. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, et al. (1997) Stability of curcumin in buffer solutions and characterization of its degradation products. Journal of pharmaceutical and biomedical analysis 15: 1867-1876.
35. Hammarstrom P, Simon R, Nystrom S, Konradsson P, Aslund A, et al. (2010) A fluorescent pentameric thiophene derivative detects in vitro-formed prefibrillar protein aggregates. Biochemistry 49: 6838-6845.
36. Alavez S, Vantipalli MC, Zucker DJ, Klang IM, Lithgow GJ, (2011) Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 472: 226-229.
37. Minniti AN, Rebolledo DL, Grez PM, Fadic R, Aldunate R, et al. (2009) Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification. Mol Neurodegener 4: 2.
38. Rival T, Page RM, Chandraratna DS, Sendall TJ, Ryder E, et al. (2009) Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci 29: 1335-1347.
39. Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB, (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 117: 236-245.
40. Necula M, Kayed R, Milton S, Glabe CG, (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282: 10311-10324.
41. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, et al. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4: 887-893.
42. Brorsson AC, Bolognesi B, Tartaglia GG, Shammas SL, Favrin G, et al. (2010) Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide. Biophysical journal 98: 1677-1684.
43. Reinke AA, Gestwicki JE, (2007) Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70: 206-215.
44. Lin DM, Goodman CS, (1994) Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13: 507-523.
45. Hay BA, Wolff T, Rubin GM, (1994) Expression of baculovirus P35 prevents cell death in Drosophila. Development 120: 2121-2129.
46. Kaplan EL, Meier P, (1958) Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association 53: 457-481.
47. Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Polymenidou M, et al. (2007) Prion strain discrimination using luminescent conjugated polymers. Nat Methods 4: 1023-1030.
48. Philipson O, Hammarström P, Nilsson KP, Portelius E, Olofsson T, et al. (2009) A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice. Neurobiol Aging 30: 1393-1405.
49. Nilsson KP, Åslund A, Berg I, Nystrom S, Konradsson P, et al. (2007) Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol 2: 553-560.